Taclonex Suspension
Product Images NDC 50222-501

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Taclonex (NDC 50222-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leo Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Taclonex 01

Chemical structure diagram of calcipotriene, an active ingredient in TACLONEX topical suspension. The structure shows hydroxyl groups and a water molecule (H2O) indicating its hydrated form.*

FDA Label Image

Taclonex 02

Chemical structure diagram depicting the molecular structure of the active ingredients in TACLONEX, specifically calcipotriene and betamethasone dipropionate.*

FDA Label Image

Taclonex 03

An instructional diagram showing a hand holding a tube labeled 'Taclonex' with arrows indicating a squeezing motion of the tube. The illustration is marked with the letter 'A' in a circle, suggesting it is part of step-by-step usage instructions.*

FDA Label Image

Taclonex 04

An illustration showing a close-up of a person's forehead with horizontal lines indicating affected skin areas, labeled with the letter 'B' in a small circle on the lower left. The image suggests a dermatological context, possibly for topical treatment application guidance.*

FDA Label Image

Taclonex 05

Illustration showing a hand dispensing TACLONEX suspension from a bottle onto a surface or application area, demonstrating the topical application method for this prescription drug.*

FDA Label Image

Taclonex 06

Instructional illustration labeled with a letter D showing a person applying topical suspension to the scalp using hands, indicating the proper technique for applying the medication to the scalp area.*

FDA Label Image

Taclonex 07

Label for Taclonex topical suspension containing calcipotriene and betamethasone dipropionate at strengths 0.005%/0.064%. The label states it is for topical use only, with net weight 60 grams. It includes storage instructions, manufacturer (LEO Laboratories Ltd, Ireland), and distributor (LEO Pharma Inc, Madison, NJ). The NDC number 50222-501-06 is displayed along with barcode and trademarked LEO logo featuring a lion.*

FDA Label Image

Taclonex 08

Packaging label for Taclonex (calcipotriene and betamethasone dipropionate) topical suspension, 0.005%/0.064%, with a net weight of 120 grams composed of 2 bottles of 60 grams each. The label states "Shake before use" and "For Topical Use Only," includes the NDC 50222-501-66, and highlights that individual 60 gram bottles are not for individual retail sale. Manufacturer is LEO Laboratories Ltd., Dublin, Ireland, and distributed by LEO Pharma Inc., Madison, NJ, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.